Yi S, An H, Lee H, Lee S, Ieiri I, Lee Y, Cho JY, Hirota T, Fukae M, Yoshida K, Nagatsuka S, Kimura M, Irie S, Sugiyama Y, Shin DW, Lim KS, Chung JY, Yu KS, Jang IJ. Korean, Japanese, and Chinese populations featured similar genes encoding drug-metabolizing enzymes and transporters: a DMET Plus microarray assessment. Pharmacogenetics and genomics. 2014;24(10):477-485.

Lee H, Jang I-J, Yu K-S, Choi J, Oh B-H. A Population Pharmacokinetic Analysis of Fimasartan, a Selective Angiotensin II Receptor Antagonist, in Healthy Caucasian Subjects and Korean Patients With Hypertension. Clinical Pharmacology in Drug Development. 2013;2(2):162-72. doi: 10.1002/cpdd.10.

Lee H, Kim KS, Chae SC, Jeong MH, Kim DS, Oh BH. Ambulatory Blood Pressure Response to Once-Daily Fimasartan: An 8-Week, Multicenter, Randomized, Double-Blind, Active-Comparator, Parallel-Group Study in Korean Patients With Mild To Moderate Essential Hypertension. Clin Ther. 2013;35(9):1337-49. doi: 10.1016/j.clinthera.2013.06.021.

Lee H, Yang H-M, Lee H-Y, Kim J-J, Choi D-J, Seung K-B, Jeon E-S, Ha J-W, Rim S-J, Park JB, Shin J-H, Oh B-H. Efficacy and Tolerability of Once-Daily Oral Fimasartan 20 to 240 mg/d in Korean Patients with Hypertension: Findings from Two Phase II, Randomized, Double-Blind, Placebo-Controlled Studies. Clin Ther. 2012;34(6):1273-1289.

Lee H. Let Us Not Forget Woo-Suk Hwang. The Young Physicians Press. Seoul, Korea, 2007 (ISBN: 8991232124).

Lee H. Chapter 1. Disappearance of Biomedical Science, Destruction of Research Ethics. In: Hwang Woo Suk’s Scandal. Hannarae Publishing Co., Seoul, Korea (ISBN : 9788955660487)

Lee H. Good Review Practices are the first step forward for the Korea Food and Drug Administration, Drug Information Journal 2005;39: 185-192.